Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vagotonic Effect of Remifentanil in Reference to Sympathetic or Parasympathetic Predominance of Autonomic Nervous System.

NCT01714388 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.

NCT NCT01714388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01714388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vagotonic Effect of Remifentanil in Reference to Sympathetic or Parasympathetic Predominance of Autonomic Nervous System.
Lead sponsor
Medical University of Gdansk
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2010
Completion date
March 31, 2015
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autonomic nervous system activity